argenx SE - stock earnings
ARGX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -172.1 million USD | 737.7 million USD |
| 2023Q3 | -72.6 million USD | 329.8 million USD |
| 2023Q2 | -94.4 million USD | 270.6 million USD |
| 2023Q1 | -28.9 million USD | 219.1 million USD |
| 2022Q4 | -38.6 million USD | 174.2 million USD |
| 2022Q3 | -235.0 million USD | 138.0 million USD |
| 2022Q2 | -208.7 million USD | 75.2 million USD |
| 2022Q1 | -227.2 million USD | 23.4 million USD |
| 2021Q4 | -237.8 million USD | 26.0 million USD |
| 2021Q3 | -233.6 million USD | 857000 USD |
| 2021Q2 | 103.6 million USD | 312.2 million USD |
| 2021Q1 | -40.4 million USD | 158.2 million USD |
| 2020Q4 | 288.9 million USD | -3.7 million USD |
| 2020Q3 | -157.7 million USD | 11.5 million USD |
| 2019Q4 | -92.9 million USD | 17.5 million USD |
| 2019Q3 | -24.9 million USD | 8.7 million USD |
| 2019Q2 | -58.9 million USD | 8.6 million USD |
| 2019Q1 | 7.6 million USD | 40.9 million USD |
| 2018Q4 | -33.9 million USD | 1.4 million USD |
| 2018Q3 | -19.1 million USD | 2.4 million USD |
| 2018Q2 | -1.4 million USD | 13.8 million USD |
| 2018Q1 | -21.8 million USD | 6.9 million USD |
| 2017Q4 | -14.3 million USD | 10.3 million USD |
| 2017Q3 | -10.0 million USD | 7.7 million USD |
| 2017Q2 | -387547 USD | 18.6 million USD |
| 2017Q1 | -9.0 million USD | 7.1 million USD |
| 2016Q4 | -8.4 million USD | 3.7 million USD |
| 2016Q3 | -5.9 million USD | 5.5 million USD |
| 2016Q2 | -4.8 million USD | 3.8 million USD |
| 2016Q1 | -3.4 million USD | 2.5 million USD |
| 2015Q4 | -5.4 million USD | 1.9 million USD |
| 2015Q3 | -3.5 million USD | 2.6 million USD |
| 2015Q2 | -4.6 million USD | 1.7 million USD |
| 2015Q1 | -3.2 million USD | 1.3 million USD |
| 2014Q4 | -4.6 million USD | 1.8 million USD |
| 2014Q3 | -1.7 million USD | 2.0 million USD |
| 2014Q2 | -3.7 million USD | 308661 USD |
| 2014Q1 | -2.6 million USD | 468986 USD |
| 2013Q4 | -2.1 million USD | 934372 USD |
| 2013Q3 | -102691 USD | 1.7 million USD |
| 2013Q2 | -4.0 million USD | 530612 USD |
| 2013Q1 | -2.3 million USD | 559625 USD |
ARGX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -234.5 million USD | 993.6 million USD |
| 2022 | -709.6 million USD | 410.7 million USD |
| 2021 | -408.3 million USD | 497.3 million USD |
| 2020 | -650.5 million USD | 44.8 million USD |
| 2019 | -182.5 million USD | 78.2 million USD |
| 2018 | -76.2 million USD | 24.6 million USD |
| 2017 | -33.7 million USD | 43.7 million USD |
| 2016 | -22.5 million USD | 15.5 million USD |
| 2015 | -16.7 million USD | 7.5 million USD |
| 2014 | -12.5 million USD | 4.6 million USD |
| 2013 | -8.5 million USD | 3.7 million USD |
| 2012 | -12.8 million USD | 2.2 million USD |
| 2011 | -4.5 million USD | 1.5 million USD |
ARGX
Price: $388.20
52 week price:
Earnings Per Share: -5.14 USD
P/E Ratio: -95.08
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 205974
Ebitda: -24.6 millionMarket Capitalization: 22.9 billion